SOST and sclerosteosis: Sclerosteosis patients lack sclerostin due to homozygous mutations in the sclerostin-encoding gene SOST [2,5], but heterozygous carriers have an increased bone mineral density suggesting a gene dosage effect for sclerostin [6].